South America Genome Editing Market Growth Opportunities and Forecast by 2028

South America Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)

Report Date : Mar 2022
Report Code : TIPRE00027828

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 125

The genome editing market in South America is expected to grow from US$ 319.10 million in 2021 to US$ 1,003.03 million by 2028; it is estimated to grow at a CAGR of 17.8% from 2021 to 2028.

Technological developments in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems. Developers working in the healthcare IT domain are engaged in analyzing the processes to control and monitor all the stages of product development. The focus is to develop technologies from discovering biomarkers to clinical trials and patient monitoring. A few companies have initiated implementing their expertise to use AI for digital manufacturing. In March 2019, Oxford Biomedica plc collaborated with Microsoft Research for R&D of cloud and machine learning to improve the production and quality of next-generation gene therapy vectors such as LentiVector. Under this collaboration, Oxford Biomedica has utilized Microsoft’s Azure intelligent cloud platform to develop in silico models and innovative algorithms to advance the next-generation cell and gene delivery technology. Similarly, in June 2018, Celixir plc acquired Desktop Genetics to develop CRISPR-based gene editing. In August 2018, bluebird bio, Inc. and Gritstone Oncology, Inc. collaborated to develop and commercialize cell therapy products intended for cancer treatment. Under the agreement, Gritstone Oncology has utilized its proprietary EDGE artificial intelligence platform to analyze specific tumor types. EDGE AI platform has helped identify tumor-specific targets and natural T-cell receptors (TCRs) that are used as targets by bluebird bio to develop cell therapies. Further, Gritstone Oncology has utilized those identified targets to conduct development, manufacturing, and commercial processes. Thus, such innovations are expected to foster genome editing and enhance the market growth in the coming years.The outbreak of COVID–19 has stringently affected medical services in the South America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is affected by the second wave of corona infection. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the emerging new variants of the COVID19 virus. Amongst which Brazil has registered the majority of the deaths. It is anticipated that the region will likely force a restriction of the international travelers, which will ultimately affect the healthcare industry in the area.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America genome editing market. The South America genome editing market is expected to grow at a good CAGR during the forecast period.

South America Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Inquire for Discount

Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Request discounts available for Start-Ups & Universities

South America Genome Editing Market Segmentation

South America Genome Editing Market – By Technology

CRISPR
TALEN
Antisense
Other

South America Genome Editing Market – By Application

Cell Line Engineering
Genetic Engineering
Diagnostic Applications
Drug Discovery
Others

South America Genome Editing Market – By End User

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Clinical Research Organizations (CRO's)

South America Genome Editing Market – By Country

Brazil
Argentina
Rest of South America

South America Genome Editing Market – Companies Mentioned

THERMO FISHER SCIENTIFIC INC.
MERCK KGaA
Lonza
Horizon Discovery Group plc.
GenScript
New England Biolabs
Eurofins Scientific
CRISPR Therapeutics

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

This text is related
to segments covered.

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South America Genome Editing Market– By Technology

1.3.2 South America Genome Editing Market– By Application

1.3.3 South America Genome Editing Market– By End User

1.3.4 South America Genome Editing Market– By Country

2. South America Genome Editing Market– Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South America Genome Editing Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 South America PEST Analysis

4.3 Expert Opinion

5. South America Genome EditingMarket – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Cancer and Other Genetic Disorders

5.1.2 Uplifting Technological Advancements in Gene-Editing Tools

5.2 Market Restraints

5.2.1 High Price of Genomic Equipment

5.3 Market Opportunities

5.3.1 Flourishing Developing Biotechnology Industry in Emerging Regions

5.4 Future Trends

5.4.1 Advancing Technological Innovations

5.5 Impact Analysis

6. South America Genome Editing Market Analysis

6.1 South America Genome Editing Market Revenue Forecast and Analysis

7. South America Genome Editing Market Revenue and Forecasts to 2028– by Technology

7.1 Overview

7.2 South America Genome Editing Market, By Technology, 2021 & 2028 (%)

7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

7.3.1 Overview

7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.4 TALEN

7.4.1 Overview

7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.5 Antisense

7.5.1 Overview

7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8. South America Genome Editing Market Revenue and Forecasts to 2028 – Application

8.1 Overview

8.2 South America Genome Editing Market Share, By Application - 2021 & 2028 (%)

8.3 Cell Line Engineering

8.3.1 Overview

8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Genetic Engineering

8.4.1 Overview

8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.5 Diagnostic Applications

8.5.1 Overview

8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.6 Drug Discovery

8.6.1 Overview

8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9. South America Genome Editing Market Revenue and Forecasts to 2028 – End User

9.1 Overview

9.2 South America Genome Editing Market Share by End User - 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.4 Clinical Research Organizations (CRO’s)

9.4.1 Overview

9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10. South America Genome Editing Market Revenue and Forecasts to 2028 – Country Analysis

10.1 Overview

10.1.1 South America: Genome Editing Market, by Country, 2021 & 2028 (%)

10.1.1.1 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4 Argentina: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.1.1.1.5 Argentina: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Overview

10.1.2.1.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3 Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.4 Brazil: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.1.2.1.5 Brazil: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2 Rest of SAM: Genome Editing Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Overview

10.1.2.2.2 Rest of SAM: Genome Editing Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3 Rest of SAM: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.4 Rest of SAM: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.1.2.2.5 Rest of SAM: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on South America Genome Editing Market

11.1 South America: Impact Assessment of COVID-19 Pandemic

12. South America Genome Editing Market– Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 MERCK KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Lonza

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Horizon Discovery Group plc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 GenScript

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 New England Biolabs

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Eurofins Scientific

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 CRISPR Therapeutics

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 Glossary of Terms

LIST OF TABLES

Table 1. Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 2. Argentina: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 3. Argentina: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4. Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 5. Brazil: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 6. Brazil: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. Rest of SAM: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 8. Rest of SAM: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 9. Rest of SAM: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. Organic Developments Done by Companies

Table 11. Inorganic Developments Done by Companies

Table 12. Glossary of Terms, South America Genome Editing Market

LIST OF FIGURES

Figure 1. South America Genome Editing Market Segmentation

Figure 2. South America Genome Editing Market Segmentation, By Country

Figure 3. South America Genome Editing Market Overview

Figure 4. CRISPR Held Largest Share of Technology Segment in South America Genome Editing Market

Figure 5. Brazil to Show Remarkable Growth During Forecast Period

Figure 6. South America Genome Editing Market, Industry Landscape

Figure 7. South America: PEST Analysis

Figure 8. Expert Opinion

Figure 9. South America Genome Editing Market Impact Analysis of Drivers and Restraints

Figure 10. South America Genome Editing Market– Revenue Forecast and Analysis – 2019-2028

Figure 11. South America Genome Editing Market, by Technology, 2021 & 2028 (%)

Figure 12. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. South America Genome Editing Market Share, by Application - 2021 & 2028 (%)

Figure 17. Cell Line Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Genetic Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Diagnostic Applications: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Drug Discovery: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Others: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. South America Genome Editing Market Share by End User - 2021 & 2028 (%)

Figure 23. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. South America: Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 27. South America: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 28. Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. Rest of SAM: Genome Editing Market– Revenue and Forecast to 2028 (USD Million)

Figure 31. Impact Of COVID-19 Pandemic in South America Africa Country Markets

THERMO FISHER SCIENTIFIC INC.
MERCK KGaA
Lonza
Horizon Discovery Group plc.
GenScript
New England Biolabs
Eurofins Scientific
CRISPR Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.